✦ LIBER ✦

Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae

✍ Scribed by Margaret R Hammerschlag; Patricia M Roblin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of moxifloxacin for treatment o

✍ C. Fogarty; A. Torres; S. Choudhri; D. Haverstock; J. Herrington; J. Ambler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Clinical and microbiological aspects of

✍ Cardinal-Fernández, P.; García Gabarrot, G.; Echeverria, P.; Zum, G.; Hurtado, J 📂 Article 📅 2013 🏛 Elsevier ⚖ 374 KB

Efficacy and safety of sequential IV/PO

✍ H Lode,S Choudhri,D Haverstock,P Jackson,D Church 📂 Article 📅 2002 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 1021 KB

Efficacy and safety of sequential moxifl

✍ G. Hoeffken; D. Talan; L. S. Larsen; S. Peloquin; S. H. Choudhri; D. Haverstock; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 72 KB

Efficacy and safety of intravenous moxif

✍ Shuyun Xu; Shengdao Xiong; Yongjian Xu; Jin Liu; Huiguo Liu; Jianping Zhao; Wein 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 Chinese ⚖ 127 KB

Multiplex PCR for the simultaneous detec

✍ Naoyuki Miyashita; Atsushi Saito; Shigeru Kohno; Keizo Yamaguchi; Akira Watanabe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 197 KB